NA
AGN

NewEdge Advisors’s Allergan plc AGN Stock Holding History

NewEdge Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,370
Closed -$420K – 957
2020
Q1 		$420K Buy
2,370
+819
+53% +$154K 0.02% 504
2019
Q4 		$297K Buy
+1,551
New +$280K 0.01% 664
2018
Q4 		– Sell
-2,577
Closed -$491K – 740
2018
Q3 		$491K Buy
2,577
+118
+5% +$21.7K 0.04% 364
2018
Q2 		$411K Sell
2,459
-31
-1% -$4.98K 0.04% 341
2018
Q1 		$404K Buy
2,490
+490
+25% +$82.2K 0.05% 300
2017
Q4 		$341K Buy
+2,000
New +$359K 0.05% 291
2017
Q3 		– Sell
-955
Closed -$230K – 1267
2017
Q2 		$230K Sell
955
-305
-24% -$71.7K 0.04% 293
2017
Q1 		$300K Buy
1,260
+5
+0.4% +$1.16K 0.07% 212
2016
Q4 		$273K Buy
1,255
+276
+28% +$57.2K 0.08% 202
2016
Q3 		$226K Buy
+979
New +$239K 0.07% 190

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

NewEdge Advisors's AGN Position: Q2 2020 in Review

NewEdge Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,370 shares — an estimated $420K sold.

NewEdge Advisors first reported a position in AGN in Q3 2016 and held it in 10 quarters. The position peaked at $491K in Q3 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • NewEdge Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • NewEdge Advisors sold 2,370 Allergan plc shares in Q2 2020, an estimated $420K.
  • NewEdge Advisors first reported a position in Allergan plc in Q3 2016 and held it in 10 quarters.
  • NewEdge Advisors's Allergan plc position peaked at $491K in Q3 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on NewEdge Advisors's 13F filing for Q2 2020, filed 29 Jul 2020.